VeriMomVeriMom

tussilago farfara leaf extract hamilelikte güvenli mi?

Tussilago farfara extracts are known to contain hepatotoxic and genotoxic pyrrolizidine alkaloids; animal studies show tumorigenicity and case reports link PA‑containing herbal use in pregnancy to infant liver damage, supporting a suspected reproductive/ developmental hazard (h=2). Evidence indicates a demonstrated toxic mechanism for PAs (genotoxic/hepatotoxic) rather than a purely theoretical structural alert (m=2). For topical cosmetic use, systemic exposure is expected to be low but measurable if PAs are present in the extract (e=1). (ECHA substance entry; PubMed carcinogenicity study; EFSA/PA reviews).

İçerikler
tussilago farfara leaf extract
ORTA RISK
40
/100
0

Hamilelikte tussilago farfara leaf extract yerine kullanılabilecek güvenli alternatifler | VeriMom

Related ingredients

Frequently asked questions

tussilago farfara leaf extract hamilelikte güvenli mi?
Tussilago farfara extracts are known to contain hepatotoxic and genotoxic pyrrolizidine alkaloids; animal studies show tumorigenicity and case reports link PA‑containing herbal use in pregnancy to infant liver damage, supporting a suspected reproductive/ developmental hazard (h=2). Evidence indicates a demonstrated toxic mechanism for PAs (genotoxic/hepatotoxic) rather than a purely theoretical structural alert (m=2). For topical cosmetic use, systemic exposure is expected to be low but measurable if PAs are present in the extract (e=1). (ECHA substance entry; PubMed carcinogenicity study; EFSA/PA reviews).
tussilago farfara leaf extract emzirirken güvenli mi?
Same hazard drivers apply during lactation—PAs are hepatotoxic/genotoxic and have been implicated in neonatal/infant liver injury after maternal herbal use. Mechanistic data for PA toxicity apply (m=2). Topical use would generally give low but potentially measurable systemic exposure (e=1), so transfer in milk is plausible if maternal systemic levels occur. (ECHA; EFSA PA opinion; case reports and toxicology literature).
tussilago farfara leaf extract bebek cildi için güvenli mi?
No infant‑specific studies found, so hazard and mechanism remain those from PA toxicity (h=2, m=2). Because infant skin has higher absorption (immature barrier, higher surface‑area:weight) and PAs are small molecule toxins that can be systemically available, exposure score is increased by +1 relative to adult topical use (adult e=1 → baby e=2). No data justify raising hazard or mechanism beyond adult scores. (EFSA/PA reviews; toxicology literature).
VeriMom tussilago farfara leaf extract nasıl puanlıyor?
VeriMom tussilago farfara leaf extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 40/100 (orta risk) olarak puanlar.
Hamilelikte tussilago farfara leaf extract yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin